共 50 条
- [43] Differences in pharmacokinetic behaviour of branded enoxaparin and a US generic version in a non-human primate model [J]. GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2015, 4 (02): : 72 - 78
- [44] GENERIC SUBSTITUTES ARE NEITHER AS SAFE NOR EFFECTIVE AS BRANDED MEDICATIONS: EXPERIENCE IN MEN TREATED FOR LOWER URINARY TRACT SYMPTOMS (LUTS) [J]. JOURNAL OF UROLOGY, 2009, 181 (04): : 649 - 649
- [45] Pharmacodynamic differences between biosimilar and branded enoxaparins with reference to their immunogenic profile [J]. FASEB JOURNAL, 2010, 24
- [48] Clinical Equivalence between Generic Versus Branded Antibiotics: Systematic Review and Meta-Analysis [J]. ANTIBIOTICS-BASEL, 2023, 12 (05):
- [49] Comparing the Incidence of Febrile Neutropenia Resulting in Hospital Admission Between the Branded Docetaxel and the Generic Formulations [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (02): : 275 - 279